![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Recom Secures $5 Million in Private Placement
Recom Secures $5 Million in Private Placement
April 4, 2005
Recom Managed Systems announced the completion of private placement financing of $5 million with an institutional investor at $3.20 per share, with no commissions or other fees payable. Recom also issued warrants to purchase an additional 1,500,000 common shares at $1.60 per share. The financing will be used in large part to support commercialization of Recom's Model 100 Heart Monitor 12-lead electrocardiograph technology, which utilizes a patented signal-processing platform to allow for the production and recording of a clinical-quality ECG while the patient is ambulatory.
MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqKZvubKbmdKXyJy1nZy)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct